Staidson and Pivotal are collaborating in the conduct of a clinical trial in Europe in severe COVID-19 patients

by Pivotal

Staid​son, a biopharmaceutical company developing investigational products by targeting the complement system and Pivotal, a European-wide full-service CRO, headquartered in Madrid, have announced t...

Read more

Un producto de terapia génica para una enfermedad hepática rara recibe la designación de medicamento huérfano en EE. UU. y Europa

by CIMA - Centro de Investigación Médica Aplicada

VTX-803, co-desarrollado por el Cima Universidad de Navarra y Vivet Therapeutics, está indicado para el tratamiento de la colestasis intrahepática familiar progresiva de tipo 3

Read more

Palobiofarma joins the fight against the Covid-19 pandemia

by Palobiofarma

The company announced the initiation a of a drug discovery program towards the identification of novel oral drugs specifically designed to treat infections caused by Corona viruses.

Read more

Demuestran el impacto del infiltrado inmune intratumoral en el pronóstico de carcinoma de cabeza y cuello no relacionado con VPH

by CIBERONC - Centro de Investigación Biomédica en Red, Cáncer

Investigadores del Programa de Tumores Respiratorios del CIBERONC han demostrado el impacto del infiltrado inmune intratumoral en el pronóstico de pacientes con carcinoma de cabeza y cuello no relaci...

Read more

Supercomputing to find drugs against SARS-CoV-2

by CSIC - Centro Superior de Investigaciones Científicas

The COVID-19 fund of the Carlos III Health I​nstitute (ISCIII) awards a project to the Barcelo​na Supercomputing Center (BSC), lead by Víctor Guallar, in collaboration of No​strum Biodiscovery ...

Read more

Descrito el primer caso de VIH resistente a todas las combinaciones de tratamientos antirretrovirales

by IrsiCaixa

La revista ‘The Lancet Microbe’ publica un estudio, liderado por IrsiCaixa, que describe el caso de un hombre portador del VIH cuyo virus es resistente a todos los fármacos antirretrovirales oral...

Read more

AbilityPharma publishes full characterization of mechanism of action of ABTL0812, a Phase II clinical inducer of cytotoxic autophagy in cancer cells, in Autophagy journal

by Ability Pharma

The biopharmaceutical company Ability Pharmaceuticals SL announced today that the full description of the mechanism of action of ABTL0812 has been published in the prestigious Autophagy journal (impac...

Read more

New pathway to attack tumor cells identified

by CSIC - Centro Superior de Investigaciones Científicas

A study led by researchers from the Institut de Neurociències (INc-UAB), in collaboration with the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), describes a new mechanism by which the an...

Read more

Ysios Capital presents its third fund of € 200M

by Ysios Capital

Ysios Capital, a leading biotechnology venture capital firm in Spain, today announced its third fund, Ysios BioFund III, with a committed amount of € 155M and a final target size of € 200M.

Read more

Una técnica de relajación podría mejorar los niveles de ansiedad de pacientes oncológicos

by Instituto de Investigación Marqués de Valdecilla

El artículo “Cancer Patients and Anxiety: A Gender Perspective” publicado en “International Journal of Environmental Research and Public Health” forma parte de un estudio que recibió el prim...

Read more

The biotech company, Oxolife, raises 5 million euros for its Phase II Clinical Trial

by Oxolife

The biotech company Oxolife, created to develop a new treatment to improve the female fertility rate, completed its first funding round by raising 5,000,000 euros in an investment led by Inveready Ass...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Identifican potenciales biomarcadores te...

by CIBERDEM - Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas

Se han presentado los nuevos biomarcadores identificados a partir de l...

Photos Stream